Universal Beteiligungs und Servicegesellschaft mbH Sells 10,527 Shares of Tenet Healthcare Corporation $THC

Universal Beteiligungs und Servicegesellschaft mbH lessened its stake in Tenet Healthcare Corporation (NYSE:THC) by 16.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 54,527 shares of the company’s stock after selling 10,527 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Tenet Healthcare were worth $10,863,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Eminence Capital LP acquired a new stake in Tenet Healthcare in the third quarter valued at $225,263,000. Boston Partners increased its stake in shares of Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares during the last quarter. AQR Capital Management LLC lifted its stake in Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after purchasing an additional 720,160 shares during the last quarter. Alliancebernstein L.P. grew its holdings in Tenet Healthcare by 375.7% during the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after purchasing an additional 624,125 shares during the period. Finally, WCM Investment Management LLC increased its position in Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after buying an additional 362,083 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Truist Financial raised their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Royal Bank Of Canada increased their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. Wall Street Zen cut shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Guggenheim increased their price objective on shares of Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Finally, TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $250.56.

Insiders Place Their Bets

In other news, EVP Thomas W. Arnst sold 8,000 shares of Tenet Healthcare stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the sale, the executive vice president directly owned 12 shares in the company, valued at approximately $2,866.20. The trade was a 99.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 46,517 shares of company stock worth $10,943,111 in the last quarter. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Stock Performance

NYSE:THC opened at $180.72 on Monday. The stock has a 50 day simple moving average of $211.42 and a 200 day simple moving average of $204.68. The stock has a market cap of $15.83 billion, a P/E ratio of 11.67, a PEG ratio of 1.36 and a beta of 1.49. Tenet Healthcare Corporation has a 1-year low of $120.74 and a 1-year high of $247.21. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the business earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 17.31 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.